1. World Health Organization. (1972). International drug monitoring: the role of national centres. WHO Technical Report Series, no. 498, pp. 1–25.
2. Edwards, I. R., & Aronson, J. K. (2000). Adverse drug reactions: definitions, diagnosis, and management. Lancet, 356(9237), 1255–1259.
3. What is a serious event? http:/www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm . Accessed 18 February 2013.
4. Meyer, U. A. (2000). Pharmacogenetics and adverse drug reactions. Lancet, 356(9237), 1667–1671.
5. Coombs, R. R. A., & Gell, P. G. H. (1975). Classification of allergic reactions responsible for clinical hypersensitivity and disease. In P. G. H. Gell, R. R. A. Coombs, & P. J. Lachmann (Eds.), Clinical aspects of immunology (pp. 761–781). Oxford: Blackwell.